Ken Fisher Fisher Asset Management
Ken Fisher is the founder and executive chairman of Fisher Investments, a global money management firm overseeing billions of dollars in assets. He gained early recognition for pioneering the use of the price-to-sales ratio in stock analysis and wrote the long-running “Portfolio Strategy” column in Forbes. Over the years, Fisher has authored numerous books on investing and wealth management, many of which have become bestsellers.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$2.87B |
| 2 |
NVIDIA
NVDA
|
+$358M |
| 3 |
Suncor Energy
SU
|
+$287M |
| 4 |
Microsoft
MSFT
|
+$278M |
| 5 |
Apple
AAPL
|
+$200M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$1.8B |
| 2 |
Canadian Natural Resources
CNQ
|
+$205M |
| 3 |
Intuit
INTU
|
+$177M |
| 4 |
Adobe
ADBE
|
+$120M |
| 5 |
GTLS
Chart Industries
GTLS
|
+$95.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.4% |
| 2 | Financials | 18.68% |
| 3 | Industrials | 9.33% |
| 4 | Healthcare | 8.68% |
| 5 | Communication Services | 6.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
Coherent
COHR
$74.4B
| $40.4M | 0.01% |
375,496
+120,727
| +47% | +$12M |
|
252
Veeco
VECO
$3.19B
| $40.3M | 0.01% |
1,324,590
+325,357
| +33% | +$7.75M |
|
253
Granite Construction
GVA
$5.51B
| $39.7M | 0.01% |
362,505
-9,026
| -2% | -$927K |
|
254
Biogen
BIIB
$30.3B
| $38.8M | 0.01% |
277,285
-11,852
| -4% | -$1.6M |
|
255
SLB Ltd
SLB
$76.5B
| $38.7M | 0.01% |
1,125,010
-29,976
| -3% | -$1.04M |
|
256
Boot Barn
BOOT
$4.92B
| $37.8M | 0.01% |
228,009
+62,515
| +38% | +$10.8M |
|
257
Helmerich & Payne
HP
$3.71B
| $37.7M | 0.01% |
1,706,123
-54,418
| -3% | -$1M |
|
258
Bio-Rad Laboratories Class A
BIO
$9.25B
| $37.4M | 0.01% |
133,465
-4,277
| -3% | -$1.16M |
|
259
Abercrombie & Fitch
ANF
$4.97B
| $36.9M | 0.01% |
431,351
+40,914
| +10% | +$3.82M |
|
260
Arrowhead Research
ARWR
$12.3B
| $36.3M | 0.01% |
1,053,794
+602,139
| +133% | +$13.2M |
|
261
APA Corp
APA
$13.1B
| $35.2M | 0.01% |
1,449,546
+71,890
| +5% | +$1.52M |
|
262
Moelis & Co
MC
$5B
| $35.1M | 0.01% |
491,470
+141,221
| +40% | +$10.1M |
|
263
Agios Pharmaceuticals
AGIO
$1.9B
| $34.9M | 0.01% |
870,145
-7,395
| -0.8% | -$278K |
|
264
Baker Hughes
BKR
$62.3B
| $34.9M | 0.01% |
716,879
+33,471
| +5% | +$1.48M |
|
265
Nucor
NUE
$61.9B
| $34.5M | 0.01% |
254,510
+20,043
| +9% | +$2.84M |
|
266
Vanguard Long-Term Treasury ETF
VGLT
$10.1B
| $34.1M | 0.01% |
599,884
-108,573
| -15% | -$6.05M |
|
267
UMB Financial
UMBF
$11.1B
| $33.9M | 0.01% |
286,681
+4,420
| +2% | +$509K |
|
268
KLA
KLAC
$258B
| $33.6M | 0.01% |
311,400
-16,730
| -5% | -$1.56M |
|
269
State Street SPDR Portfolio Short Term Corporate Bond ETF
SPSB
$10.7B
| $33.5M | 0.01% |
1,105,148
-231,439
| -17% | -$6.98M |
|
270
SPX Corp
SPXC
$10.8B
| $33M | 0.01% |
176,507
+58,326
| +49% | +$10.8M |
|
|
UCB
271
United Community Banks
UCB
$4.29B
| $32.9M | 0.01% |
1,048,174
-16,755
| -2% | -$530K |
|
272
Haemonetics
HAE
$3.89B
| $32.3M | 0.01% |
662,504
-26,638
| -4% | -$1.65M |
|
273
Murphy Oil
MUR
$4.87B
| $31.7M | 0.01% |
1,117,152
-63,276
| -5% | -$1.6M |
|
274
iShares MSCI Saudi Arabia ETF
KSA
$622M
| $31.7M | 0.01% |
781,350
+20,319
| +3% | +$772K |
|
275
Crinetics Pharmaceuticals
CRNX
$8.9B
| $31.6M | 0.01% |
758,357
+21,273
| +3% | +$680K |
|
Similar funds
Ken Fisher's Q3 2025 Portfolio in Review
As of Q3 2025, Ken Fisher held 1,094 positions worth $276B, up 9.7% from $252B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Ken Fisher's Q3 2025 filing shows 108 new, 450 increased, 424 reduced and 80 closed positions. Its largest new stake was Sanmina: 166,861 shares worth $19.2M. The largest sale was Vanguard Intermediate-Term Corporate Bond ETF, an estimated $1.8B.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 25% a quarter earlier, followed by Financials and Industrials.
- Ken Fisher's largest Q3 2025 buy was Sanmina: 166,861 shares worth $19.2M.
- Ken Fisher added most to iShares 7-10 Year Treasury Bond ETF in Q3 2025, an estimated $2.87B increase.
- Ken Fisher's biggest Q3 2025 reduction was Vanguard Intermediate-Term Corporate Bond ETF, cutting an estimated $1.8B.
- Ken Fisher fully exited WEX in Q3 2025, selling an estimated $14.2M.
- Ken Fisher's ten largest holdings make up 32% of its $276B portfolio in Q3 2025.
- Ken Fisher opened 108 new positions and closed 80 in Q3 2025.
- Ken Fisher's portfolio value rose 9.7% quarter-over-quarter to $276B.
Based on Fisher Asset Management's 13F filing for Q3 2025, filed 12 Nov 2025.